89 related articles for article (PubMed ID: 16001797)
1. [Therapeutic approaches to non-erosive GERD--comparison between the Western countries and Japan].
Hongo M; Adachi M
Nihon Rinsho; 2005 Jul; 63(7):1299-303. PubMed ID: 16001797
[TBL] [Abstract][Full Text] [Related]
2. A critical assessment of the current status of non-erosive reflux disease.
Armstrong D
Digestion; 2008; 78 Suppl 1():46-54. PubMed ID: 18832840
[TBL] [Abstract][Full Text] [Related]
3. Functional heartburn and non-erosive reflux disease.
Savarino V; Savarino E; Parodi A; Dulbecco P
Dig Dis; 2007; 25(3):172-4. PubMed ID: 17827934
[TBL] [Abstract][Full Text] [Related]
4. Non-erosive reflux disease, functional heartburn and gastroesophageal reflux disease; insights into pathophysiology and clinical presentation.
Quigley EM
Chin J Dig Dis; 2006; 7(4):186-90. PubMed ID: 17054579
[TBL] [Abstract][Full Text] [Related]
5. Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities.
Martínek J; Benes M; Hucl T; Drastich P; Stirand P; Spicák J
Scand J Gastroenterol; 2008; 43(7):794-800. PubMed ID: 18584517
[TBL] [Abstract][Full Text] [Related]
6. [Perception of symptoms with minimal reductions of esophageal pH in patients with erosive and non-erosive GERD].
Remes-Troche JM; Gómez-Escudero O; Ruíz JC; Schmulson MJ; Valdovinos Díaz MA
Rev Gastroenterol Mex; 2004; 69(1):30-6. PubMed ID: 15193061
[TBL] [Abstract][Full Text] [Related]
7. The nonerosive reflux disease-gastroesophageal reflux disease controversy.
Winter JW; Heading RC
Curr Opin Gastroenterol; 2008 Jul; 24(4):509-15. PubMed ID: 18622168
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial: roxatidine vs omeprazole for non-erosive reflux disease.
Nakamura K; Akiho H; Ochiai T; Motomura Y; Higuchi N; Okamoto R; Matsui N; Yasuda D; Akahoshi K; Kabemura T; Ihara E; Harada N; Ito T; Takayanagi R
Hepatogastroenterology; 2010; 57(99-100):497-500. PubMed ID: 20698216
[TBL] [Abstract][Full Text] [Related]
9. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.
Pace F; Pace M
Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):423-7. PubMed ID: 20678016
[TBL] [Abstract][Full Text] [Related]
10. Precise role of acid in non-erosive reflux disease.
Wang C; Hunt RH
Digestion; 2008; 78 Suppl 1():31-41. PubMed ID: 18832838
[TBL] [Abstract][Full Text] [Related]
11. Stratification and symptom characteristics of non-erosive reflux disease based on acid and duodenogastroesophageal reflux.
Xiong LS; Chen MH; Lin JK; Hu PJ
J Gastroenterol Hepatol; 2008 Feb; 23(2):290-5. PubMed ID: 17924953
[TBL] [Abstract][Full Text] [Related]
12. Cardiac autonomic regulation differentiates reflux disease with and without erosive esophagitis.
Chen CL; Orr WC; Yang CC; Kuo TB
Scand J Gastroenterol; 2006 Sep; 41(9):1001-6. PubMed ID: 16938711
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis between psychological and endoscopic profiles in patients with gastroesophageal reflux disease: a prospective study based on screening endoscopy.
Lee YC; Wang HP; Chiu HM; Liao SC; Huang SP; Lai YP; Wu MS; Chen MF; Lin JT
J Gastroenterol Hepatol; 2006 May; 21(5):798-804. PubMed ID: 16704526
[TBL] [Abstract][Full Text] [Related]
14. [Esophageal pH monitoring].
Yamamoto T
Nihon Rinsho; 2007 May; 65(5):877-83. PubMed ID: 17511227
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of heartburn.
Ang D; Sifrim D; Tack J
Nat Clin Pract Gastroenterol Hepatol; 2008 Jul; 5(7):383-92. PubMed ID: 18542113
[TBL] [Abstract][Full Text] [Related]
16. Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group.
Lee KJ; Kwon HC; Cheong JY; Cho SW
Digestion; 2009; 79(3):131-6. PubMed ID: 19307735
[TBL] [Abstract][Full Text] [Related]
17. Nonerosive reflux disease.
Waring JP
Semin Gastrointest Dis; 2001 Jan; 12(1):33-7. PubMed ID: 11215854
[TBL] [Abstract][Full Text] [Related]
18. Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan.
Fujiwara Y; Higuchi K; Shiba M; Yamamori K; Watanabe Y; Sasaki E; Tominaga K; Watanabe T; Oshitani N; Arakawa T
Am J Gastroenterol; 2005 Apr; 100(4):754-8. PubMed ID: 15784015
[TBL] [Abstract][Full Text] [Related]
19. Symptom evaluation in gastroesophageal reflux disease.
Modlin IM; Moss SF
J Clin Gastroenterol; 2008; 42(5):558-63. PubMed ID: 18364584
[TBL] [Abstract][Full Text] [Related]
20. Clinical considerations in GERD (gastroesophageal reflux disease) therapy: focus on cisapride.
Snape WJ
Am J Manag Care; 1997 May; 3(5):766-71. PubMed ID: 10184748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
